June 30, 2015 | 11:51 AM by Fahad Khalid
Celgene (CELG) & Juno Therapeutics (JUNO) – Street Takeaways after CELG announces 10-year immuno-oncology deal and $1B investment in Juno Therapeutics : Leerink analyst Howard Liang – Very positive on…
Continue Reading »
